Philippe Barthelemy

Title: Innovations in Gene Delivery by Philippe Barthelemy

Introduction

Philippe Barthelemy is a notable inventor based in Mérignac, France. He has made significant contributions to the field of gene therapy through his innovative work on synthetic molecules and macromolecules designed for gene delivery. His research focuses on developing non-viral vector compositions that enhance the transfer of genetic material.

Latest Patents

Barthelemy holds a patent for "Functional synthetic molecules and macromolecules for gene delivery." This invention describes a synthetic non-viral vector composition for gene therapy, which can be utilized for in vitro, ex vivo, and in vivo transfer of genetic material. The patent proposes a pharmaceutical composition that includes either a non-cationic amphiphilic molecule or macromolecule for nucleic acid delivery, or a cationic amphiphilic molecule or macromolecule that can transform its charge state through various reactions. Additionally, the invention explores the use of these compositions in conjunction with surfaces to facilitate nucleic acid delivery and the formation of hydrogels for effective genetic material transfer.

Career Highlights

Philippe Barthelemy is associated with Fifth Base LLC, where he continues to advance his research in gene delivery systems. His work has garnered attention for its potential applications in therapeutic settings, particularly in the realm of genetic disorders.

Collaborations

Barthelemy has collaborated with notable researchers such as Mark W Grinstaff and Carla Prata, contributing to the advancement of knowledge in the field of gene therapy.

Conclusion

Philippe Barthelemy's innovative work in synthetic gene delivery systems represents a significant advancement in gene therapy. His contributions have the potential to impact the future of genetic medicine significantly.